18F-FDG PET/CT检出直肠腺癌子宫体转移
本文报告一例47岁女性直肠腺癌术后及放化疗后3年,随访出现下腹痛和肿瘤标志物升高而超声未见异常,18F-FDG PET/CT显示子宫体肌层FDG高摄取,疑子宫体转移,经MRI和诊断性刮宫病理证实为直肠腺癌子宫转移。
要点
- 直肠腺癌随访中下腹痛伴肿瘤标志物升高而超声无异常时,可考虑18F-FDG PET/CT评估。
- 18F-FDG PET/CT显示子宫体肌层FDG高摄取,提示子宫体转移可能。
- MRI和诊断性刮宫病理可补充证实直肠腺癌子宫体转移。
核心结论
- 本病例报告一例直肠腺癌子宫体转移,由18F-FDG PET/CT检出并经MRI和诊断性刮宫病理证实。
研究设计与样本
- 病例报告:一例47岁女性直肠腺癌患者,3年前接受手术和放化疗。
主要发现
- 随访中出现下腹痛和肿瘤标志物升高,超声检查未见异常。
- 18F-FDG PET/CT显示子宫体肌层强烈FDG摄取,怀疑子宫体转移。
- 补充MRI和诊断性刮宫组织病理学证实为直肠腺癌子宫转移。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We report an unusual case of uterine corpus metastasis from rectal adenocarcinoma detected using F-FDG PET/CT. A 47-year-old woman was diagnosed with rectal adenocarcinoma and treated with surgery and radiochemotherapy 3 years ago. During follow-up, she presented with lower abdomen pain and elevated tumor markers, but ultrasonography findings were unremarkable. We performed an F-FDG PET/CT scan, which showed intense F-FDG avidity in the myometrium of the uterine corpus. Uterine corpus metastasis was suspected, and complementary MRI and diagnostic curettage histopathology confirmed uterine metastasis from rectal adenocarcinoma.
引用
- Wang H, Su M, Cui F, et al. Uterine Corpus Metastasis From Rectal Adenocarcinoma Detected Using 18F-FDG PET/CT. Clin Nucl Med. 2018. PMID: 29916919. doi:10.1097/RLU.0000000000002167
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。